CO5080736A1 - Metodo de produccion de un compuesto de isoxazolidinediona - Google Patents

Metodo de produccion de un compuesto de isoxazolidinediona

Info

Publication number
CO5080736A1
CO5080736A1 CO99019141A CO99019141A CO5080736A1 CO 5080736 A1 CO5080736 A1 CO 5080736A1 CO 99019141 A CO99019141 A CO 99019141A CO 99019141 A CO99019141 A CO 99019141A CO 5080736 A1 CO5080736 A1 CO 5080736A1
Authority
CO
Colombia
Prior art keywords
compound
jpeg
formula
emi file
imf
Prior art date
Application number
CO99019141A
Other languages
English (en)
Inventor
Ando Koji
Suzuki Masanobu
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of CO5080736A1 publication Critical patent/CO5080736A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Un método para producir un compuesto de isoxazolidinediona de fórmula [11]<EMI FILE="99019141_1" ID="1" IMF=JPEG >Donde R es un grupo hidrocarburo aromático opcionalmente sustituido, un grupo hidrocarburo alicíclico oxi, un grupo heterocíclico opcionalmente sustituido o un grupo heterocíclico condensado opcionalmente sustituido, o una sal de los mismos comprendiendo las etapas dehacer reaccionar el compuesto [1]<EMI FILE="99019141_2" ID="2" IMF=JPEG >O una sal del mismo con un compuesto de la fórmula [2]<EMI FILE="99019141_3" ID="3" IMF=JPEG >En donde R es como está arriba definido, en la presencia de una base inorgánica en un solvente acuoso para dar un derivado aspartato de la fórmula [3]<EMI FILE="99019141_4" ID="4" IMF=JPEG >En donde R es como está arriba definidohacer reaccionar este compuesto con anhídrido acético usando dimetilaminopiridina como catalizador en presencia de una base seguido por calentamiento para descarboxilación para dar un compuesto de la fórmula [4]<EMI FILE="99019141_5" ID="5" IMF=JPEG >...
CO99019141A 1998-03-30 1999-03-30 Metodo de produccion de un compuesto de isoxazolidinediona CO5080736A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10409898 1998-03-30

Publications (1)

Publication Number Publication Date
CO5080736A1 true CO5080736A1 (es) 2001-09-25

Family

ID=14371652

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99019141A CO5080736A1 (es) 1998-03-30 1999-03-30 Metodo de produccion de un compuesto de isoxazolidinediona

Country Status (25)

Country Link
US (4) US6248897B1 (es)
EP (3) EP1375499A1 (es)
JP (1) JP2000143596A (es)
KR (1) KR100321608B1 (es)
CN (4) CN1781915A (es)
AR (1) AR015745A1 (es)
AT (1) ATE258931T1 (es)
AU (1) AU738200B2 (es)
BR (1) BR9906312A (es)
CA (1) CA2291620C (es)
CO (1) CO5080736A1 (es)
CZ (1) CZ296507B6 (es)
DE (1) DE69914557T2 (es)
ES (1) ES2211053T3 (es)
HU (1) HUP0003273A3 (es)
IL (1) IL133146A (es)
NO (4) NO314403B1 (es)
NZ (1) NZ501896A (es)
PE (1) PE20000359A1 (es)
RU (1) RU2180663C2 (es)
SG (1) SG73627A1 (es)
SK (1) SK161499A3 (es)
TW (1) TWI224594B (es)
WO (1) WO1999050267A1 (es)
ZA (1) ZA997705B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69914557T2 (de) * 1998-03-30 2005-01-05 Japan Tobacco Inc. Verfahren zur herstellung einer isooxazolidindion-verbindung
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6784199B2 (en) 2000-09-21 2004-08-31 Aryx Therapeutics Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
US6958355B2 (en) 2000-04-24 2005-10-25 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
PL367325A1 (en) * 2001-04-16 2005-02-21 Tanabe Seiyaku Co, Ltd. Large conductance calcium-activated k channel opener
US6696474B2 (en) * 2002-04-03 2004-02-24 Warner Lambert Co. Llc. Antidiabetic agents
US6716842B2 (en) * 2002-04-05 2004-04-06 Warner-Lambert Company, Llc Antidiabetic agents
TWI343915B (en) * 2002-10-07 2011-06-21 Hoffmann La Roche Chirale ppar agonists
DE10328174A1 (de) * 2003-06-24 2005-01-13 Bayer Healthcare Ag Verfahren zur Herstellung von Aryloxazolylethylalkohol
EP1888571A2 (en) * 2005-03-22 2008-02-20 F. Hoffmann-Roche AG New salt and polymorphs of a dpp-iv inhibitor
EP1892231A1 (en) * 2006-08-21 2008-02-27 Bayer Schering Pharma Aktiengesellschaft A large scale method for the deoxofluorination of ketones

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1859667A (en) * 1930-05-14 1932-05-24 J K Gruner Lumber Company Jointed lumber
JPS58219169A (ja) 1982-06-15 1983-12-20 Takeda Chem Ind Ltd オキサゾ−ル酢酸誘導体
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
US5059720A (en) * 1990-01-31 1991-10-22 E. I. Du Pont De Nemours And Company Hydroxy containing fluorovinyl compounds and polymers thereof
ATE116971T1 (de) * 1990-08-23 1995-01-15 Pfizer Hypoglykämische hydroxyharnstoffderivate.
CA2075553A1 (en) * 1992-08-07 1994-02-08 George Zafir Insulated panel
US5678369A (en) * 1992-12-28 1997-10-21 Ig-Technical Research Inc. Refractory/heat insulating panels
JPH07188227A (ja) 1993-12-24 1995-07-25 Japan Tobacco Inc チアゾリジン誘導体及びオキサゾール誘導体
KR0164665B1 (ko) 1993-12-27 1999-01-15 미즈노 시게루 이소옥사졸리딘디온 유도체 및 그의 용도
TW403748B (en) * 1994-11-02 2000-09-01 Takeda Chemical Industries Ltd An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same
IL120443A (en) * 1996-03-18 2000-07-16 Sankyo Co Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
US5768850A (en) * 1997-02-04 1998-06-23 Chen; Alen Method for erecting floor boards and a board assembly using the method
DE69914557T2 (de) * 1998-03-30 2005-01-05 Japan Tobacco Inc. Verfahren zur herstellung einer isooxazolidindion-verbindung
DE19851200C1 (de) * 1998-11-06 2000-03-30 Kronotex Gmbh Holz Und Kunstha Fußbodenpaneele
US8234204B2 (en) * 2000-11-13 2012-07-31 Goldman, Sachs & Co. Method and system for matching short trading positions with long trading positions

Also Published As

Publication number Publication date
CA2291620C (en) 2003-10-07
EP1375499A8 (en) 2004-09-08
DE69914557D1 (de) 2004-03-11
NO20024058L (no) 1999-11-29
SG73627A1 (en) 2000-06-20
WO1999050267A1 (fr) 1999-10-07
US20010039352A1 (en) 2001-11-08
CA2291620A1 (en) 1999-10-07
AU738200B2 (en) 2001-09-13
CN1130361C (zh) 2003-12-10
CZ422499A3 (cs) 2000-04-12
NO315198B1 (no) 2003-07-28
DE69914557T2 (de) 2005-01-05
NO20024058D0 (no) 2002-08-26
CN1232511C (zh) 2005-12-21
AR015745A1 (es) 2001-05-16
HUP0003273A2 (hu) 2002-01-28
NZ501896A (en) 2000-11-24
EP0992503B1 (en) 2004-02-04
NO315197B1 (no) 2003-07-28
NO20024059L (no) 1999-11-29
KR20010013044A (ko) 2001-02-26
EP0992503A1 (en) 2000-04-12
US6699996B2 (en) 2004-03-02
AU2854899A (en) 1999-10-18
HUP0003273A3 (en) 2002-02-28
NO20024060L (no) 1999-11-29
NO315199B1 (no) 2003-07-28
EP1384722A8 (en) 2004-09-08
IL133146A (en) 2004-02-08
RU2180663C2 (ru) 2002-03-20
EP1384722A1 (en) 2004-01-28
PE20000359A1 (es) 2000-05-17
NO20024060D0 (no) 2002-08-26
US6444827B2 (en) 2002-09-03
CN1235887C (zh) 2006-01-11
ZA997705B (en) 2000-06-27
EP0992503A4 (en) 2001-11-07
US20050159466A1 (en) 2005-07-21
EP1375499A1 (en) 2004-01-02
US20020188133A1 (en) 2002-12-12
SK161499A3 (en) 2000-06-12
CN1495174A (zh) 2004-05-12
CN1781915A (zh) 2006-06-07
CZ296507B6 (cs) 2006-03-15
NO995851L (no) 1999-11-29
CN1511833A (zh) 2004-07-14
BR9906312A (pt) 2000-07-11
NO314403B1 (no) 2003-03-17
NO20024059D0 (no) 2002-08-26
CN1272109A (zh) 2000-11-01
US6995271B2 (en) 2006-02-07
IL133146A0 (en) 2001-03-19
ATE258931T1 (de) 2004-02-15
US6248897B1 (en) 2001-06-19
ES2211053T3 (es) 2004-07-01
NO995851D0 (no) 1999-11-29
JP2000143596A (ja) 2000-05-23
TWI224594B (en) 2004-12-01
KR100321608B1 (ko) 2002-02-02

Similar Documents

Publication Publication Date Title
CO5080736A1 (es) Metodo de produccion de un compuesto de isoxazolidinediona
ES2162165T3 (es) Procedimiento para la fabricacion de simvastatina o acido mevinolinico.
ATE193516T1 (de) Verfahren zur herstellung von aromatischen carbonsäuren mit effektiver energierückgewinnung
CY1105376T1 (el) Διαδικασια για την παρασκευη διυδροξυ εστερων και παραγωγων αυτων
EP1690861A3 (en) A process for preparing duloxetine and intermediates for use therein
ES2120973T3 (es) Sal de diastereomero de acido quinolinmevalonico opticamente activo.
PT1158014E (pt) Processo para a producao de poliesteres biodegradaveis
CO5271705A1 (es) Derivados de dibenzo [b,f] azepina y su preparacion
RU99128102A (ru) Способ получения изоксазолидиндионового соединения
CO5470281A1 (es) Procedimiento de sintesis mejorado de derivados de acido naftiridin-3-carboxilico
ATE266020T1 (de) Synthese von r-(+)-alpha-liponsäure
CO5280203A1 (es) Proceso nuevo
DE69300826D1 (de) Hydrierung.
MX9304677A (es) Procedimiento para la preparacion de compuestos defenol polihidrico.
AR014939A1 (es) Proceso para purificar una solucion de un ester profarmaco de ampicilina
AR008526A1 (es) Procedimiento para preparar eteres bencilicos.
ATE520679T1 (de) Verfahren zur herstellung von (dioxolenon-4- yl)methylester-derivate
DE50100015D1 (de) Ester aromatischer Hydroxycarbonsäuren
ATE490230T1 (de) Einstufiges verfahren zur herstellung von alkoxybenzoesäurealkylester
RU94022266A (ru) Бензо (б) нафтиридины и способ их получения
MX9307492A (es) 4-hidroxi-2-nitrobutirofenona y tetrahidro-2-(o-nitrofenil)-2-furanol y metodos para su preparacion.
ES2049640A1 (es) Procedimiento paras la preparacion de acidos quinolin carboxilicos.
BR0013025A (pt) Processo para preparar ácidos via ésteres alfa-cloroepóxi
BR0016170A (pt) Processo para preparação de tienopirimidinas
CO4761060A1 (es) Proceso quimico